Muyldermans Serge

About Muyldermans Serge

Muyldermans Serge, With an exceptional h-index of 94 and a recent h-index of 60 (since 2020), a distinguished researcher at Vrije Universiteit Brussel, specializes in the field of Camel antibodies.

His recent articles reflect a diverse array of research interests and contributions to the field:

Single-domain antibody for the inhibition of neutrophil elastase activity

Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme

Camelidae single-domain antibodies against Yersinia pestis and methods of use

Instant Candida albicans Detection Using Ultra-Stable Aptamer Conjugated Gold Nanoparticles

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury

Epitope mapping of nanobodies binding the Alzheimer’s disease receptor SORLA

Orally delivered single-domain antibodies against gastrointestinal pathogens

Screening and epitope characterization of diagnostic nanobody against total and activated Bacteroides fragilis toxin

Muyldermans Serge Information

University

Position

___

Citations(all)

38987

Citations(since 2020)

16083

Cited By

28724

hIndex(all)

94

hIndex(since 2020)

60

i10Index(all)

251

i10Index(since 2020)

201

Email

University Profile Page

Google Scholar

Muyldermans Serge Skills & Research Interests

Camel antibodies

Top articles of Muyldermans Serge

Single-domain antibody for the inhibition of neutrophil elastase activity

2025

Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme

Molecules

2024/3/22

Camelidae single-domain antibodies against Yersinia pestis and methods of use

2024/2/6

Instant Candida albicans Detection Using Ultra-Stable Aptamer Conjugated Gold Nanoparticles

Micromachines

2024/1/31

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury

Journal of Nanobiotechnology

2023/10/11

Epitope mapping of nanobodies binding the Alzheimer’s disease receptor SORLA

Journal of Biotechnology

2023/9/20

Orally delivered single-domain antibodies against gastrointestinal pathogens

2023/7/1

Screening and epitope characterization of diagnostic nanobody against total and activated Bacteroides fragilis toxin

Frontiers in Immunology

2023/2/10

Development of highly efficient approach to PEGylate nanobodies without loss of function in lung diseases: Case of a nanobody inhibiting B. cereus b-lactamase

Revue des Maladies Respiratoires

2023/2/1

Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma

Scientific Reports

2022/12/30

Exploration of specific nanobodies as immunological reagents to detect milk allergen of β-lactoglobulin without interference of hydrolytic peptides

Journal of Agricultural and Food Chemistry

2022/11/22

Nanobodies for the early detection of ovarian cancer

International journal of molecular sciences

2022/11/8

Single Domain Antibody application in bacterial infection diagnosis and neutralization

2022/9/29

Virus-like particles and uses thereof

2022/6/16

Identification of Serum Ferritin-Specific Nanobodies and Development towards a Diagnostic Immunoassay

Biomolecules

2022/8/5

Versatile application of nanobodies for food allergen detection and allergy immunotherapy

2022/7/12

Sensitive protein detection using site-specifically oligonucleotide-conjugated nanobodies

Analytical Chemistry

2022/7/5

An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages

2022/5/31

Neutralizing dromedary-derived nanobodies against BotI-like toxin from the most hazardous scorpion venom in the Middle East and North Africa Region

Frontiers in immunology

2022/4/19

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model

EMBO molecular medicine

2022/4/7

See List of Professors in Muyldermans Serge University(Vrije Universiteit Brussel)